Takeda To Pay $22M To End Challenge To 401(k) Lineup
Takeda Pharmaceuticals agreed to pay $22 million to resolve a proposed class action accusing the company of loading its 401(k) plan with underperforming and high-cost investment options, according to a filing...To view the full article, register now.
Already a subscriber? Click here to view full article